Bacopa monnieri
An Ayurvedic adaptogen with several positive 12-week RCTs for memory and verbal learning in older adults and modest cognitive/executive gains in children with attention difficulties. Effects are slow (8–12 weeks). GI side effects are common — Bacopa is not gentle on the stomach.
Quick decision guide
May help most
Adults over 55 looking for modest improvements in verbal learning and memory; children/adolescents with inattention as an adjunct (under clinician guidance).
Common dosing range
300–450 mg/day of an extract standardized to 50% bacosides (or CDRI 08), with food.
When to expect effects
8–12 weeks minimum. Don't expect day-one effects — the trials that showed benefit all ran a full 12 weeks.
Watch out for
GI side effects (loose stools, cramping, nausea) are common, especially on empty stomach. Slows GI motility / increases secretions in animal data.
Evidence snapshot
What is it
Bacopa monnieri is a small creeping herb native to wetlands of southern Asia, where its aerial parts have been used in Ayurvedic medicine for over 1,500 years as a brain tonic (called brahmi). The bioactive compounds, primarily a group of triterpene saponins called bacosides, are concentrated in the leaves.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Memory in older adults Good Evidence | Significant improvements in AVLT delayed recall and verbal learning subtests over 12 weeks; effect sizes small-to-moderate (Cohen's d ~0.3–0.5 across tests) | Healthy adults aged 55+ noticing age-related slowing in memory who can commit to 12-week trials | 12 weeks (no shorter trials have shown benefit reliably) |
Cognitive function in healthy adults Limited Evidence | Benefit concentrated in memory free-recall tests; effect on attention/processing speed less consistent | Adults willing to commit to 12-week trials for modest memory improvements | 12 weeks |
Attention and executive function in children Limited Evidence | Cognitive flexibility, executive function, sleep routine improved; parent-rated hyperactivity behaviour not significantly changed | Children/adolescents with inattention seeking an adjunct to behavioural strategies, under clinician oversight | 16 weeks in the BACHI trial |
Anxiety and mood Mixed Evidence | Modest reductions in self-rated mood/anxiety scales as secondary outcomes; no dedicated trials in clinical depression/anxiety | Older adults already taking Bacopa for cognition who notice a mood lift as a bonus | 12 weeks (secondary endpoint in cognition trials) |
Memory in older adults
- Effect
- Significant improvements in AVLT delayed recall and verbal learning subtests over 12 weeks; effect sizes small-to-moderate (Cohen's d ~0.3–0.5 across tests)
- Best fit
- Healthy adults aged 55+ noticing age-related slowing in memory who can commit to 12-week trials
- Time
- 12 weeks (no shorter trials have shown benefit reliably)
Cognitive function in healthy adults
- Effect
- Benefit concentrated in memory free-recall tests; effect on attention/processing speed less consistent
- Best fit
- Adults willing to commit to 12-week trials for modest memory improvements
- Time
- 12 weeks
Attention and executive function in children
- Effect
- Cognitive flexibility, executive function, sleep routine improved; parent-rated hyperactivity behaviour not significantly changed
- Best fit
- Children/adolescents with inattention seeking an adjunct to behavioural strategies, under clinician oversight
- Time
- 16 weeks in the BACHI trial
Anxiety and mood
- Effect
- Modest reductions in self-rated mood/anxiety scales as secondary outcomes; no dedicated trials in clinical depression/anxiety
- Best fit
- Older adults already taking Bacopa for cognition who notice a mood lift as a bonus
- Time
- 12 weeks (secondary endpoint in cognition trials)
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Memory in older adults
Supplement benefitTwo well-designed 12-week RCTs in adults aged 55+ found Bacopa improved verbal learning, delayed recall, and memory acquisition vs placebo. Calabrese 2008 (n=54, mean age 73.5) used 300 mg/day standardized extract; Morgan & Stevens 2010 (n=98) used 300 mg/day BacoMind. Effect sizes were modest but consistent across the AVLT memory battery. GI side effects (loose stools, abdominal cramps) were notably more common in the Bacopa arm of Morgan & Stevens.
Bottom line: Real but modest cognitive benefit in older adults at 12 weeks. Use a standardized extract; expect GI side effects.
Cognitive function in healthy adults
Supplement benefitPase et al. 2012 systematic review of 6 RCTs found Bacopa improved performance on 9 of 17 memory free-recall tests across studies. Most trials enrolled healthy adults (not specifically older). Other cognitive domains (attention, executive function, learning) were less consistently studied. All trials lasted 12 weeks and used 300–450 mg/day of standardized extracts. The reviewers stressed that head-to-head comparisons against pharmacological cognitive enhancers don't exist.
Bottom line: Memory effects are the most reliable; broader 'nootropic' claims are oversold.
Attention and executive function in children
Disease adjunctKean et al. 2022 RCT in males aged 6–14 with high inattention/hyperactivity found CDRI 08 improved cognitive flexibility, executive function, interpersonal problems, and sleep routine over 16 weeks vs placebo. Notably, the primary behavioural outcome (Conners' Parent Rating Scale for hyperactivity) was not significantly different — so the trial is positive for cognition/sleep but not for parent-rated behaviour. A small systematic review of pediatric Bacopa trials reported small-to-medium effect sizes (mean d=0.42) on hyperactivity/attention with low side-effect rates (~2.3%).
Bottom line: Promising for child cognitive function under clinical supervision; not a stimulant alternative for ADHD behaviour.
Anxiety and mood
Mechanism onlyCalabrese 2008 reported reductions in self-reported depression and anxiety scores in older adults receiving Bacopa vs placebo, but this was a secondary outcome in a cognition trial, not a dedicated anxiety/depression trial. There are no large dedicated RCTs of Bacopa for clinically diagnosed anxiety or depression. Mechanism-of-action work points to serotonergic and GABA-ergic effects in animals, but human translation is weak.
Bottom line: Don't take Bacopa for mood as your primary goal — evidence is too thin compared with established options.
How it works
How to take it
What to track
Bottom line: 300 mg of standardized extract with a meal for at least 12 weeks. If GI side effects are unmanageable in the first week, try splitting the dose or switch products; if no benefit by 12 weeks, stop.
5 commercial forms
Compare the main delivery options and what they’re best suited for.
Bacopa monnieri standardized extract (50% bacosides)
Best studiedThe form used in most positive cognitive RCTs. Standardized to a minimum percentage of bacosides (typically 50%, sometimes 20–55% depending on brand). 300–450 mg/day is the studied range.
Most reliable form — standardization is what makes dose-response possible.
CDRI 08 (branded standardized extract)
RCT-gradePatented extract developed by the Central Drug Research Institute (India). Used in the Stough trials, BACHI pediatric trial, and several adult cognitive trials. Standardized to 55% bacosides A and B.
Same standardization standard as generic 50%+ extracts; brand-recognition premium.
BacoMind
RCT-gradeBranded extract used in the Morgan & Stevens 2010 trial in older adults. Standardized blend of bacosides; one of the better-documented branded forms.
Established trial dosing data (300 mg/day for 12 weeks).
Bacognize / Synapsa
Common brandedOther branded standardized extracts with some clinical research. Comparable to CDRI 08 / BacoMind for dosing purposes; pick based on availability and third-party testing.
Same standardization category as other branded extracts.
Whole-plant Bacopa powder
InconsistentTraditional Ayurvedic form. Bacoside content varies dramatically by source, season, and processing — meaning the same dose by weight can give very different active-ingredient levels. Not recommended if you want to replicate trial doses.
Highly variable; not reliable for evidence-based dosing.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Significant GI symptoms (loose stools, cramps, nausea) were notably more common in the Bacopa arm of the 2010 Morgan & Stevens RCT — about 1 in 4 participants reported them at 300 mg/day.
Bradycardia and hypothyroidism risk in theory from animal data — clinically meaningful interactions in humans are not well documented but warrant monitoring if used long-term with thyroid medication.
Who should avoid it
- People with active IBS, IBD, or chronic GI sensitivity — the GI side-effect rate is too high to be worth it.
- Pregnant or breastfeeding women — no safety data; animal data suggest possible fertility effects in males.
- People on thyroid hormone replacement — possible additive effect on thyroid function based on animal data; monitor TSH if combined.
- Anyone on sedatives, anticonvulsants, or anticholinergic medications — Bacopa may modulate these systems; discuss with prescriber.
Pregnancy & breastfeeding
Safety in pregnancy and lactation has not been established. Avoid in pregnancy and while breastfeeding; some animal data suggest reproductive effects in males.
Bottom line: Generally well tolerated when taken with food, but GI side effects are common and real. Avoid in pregnancy/breastfeeding; check with clinician if on thyroid, sedative, or anticholinergic medications.
Interactions
Animal data suggest Bacopa may increase thyroid hormone activity. People on thyroid replacement should monitor TSH if combining.
Bacopa has mild sedative effects in animal models; combining could increase sedation. Use cautiously.
Bacopa enhances cholinergic activity; may counteract anticholinergic drugs. Theoretical concern; clinical data limited.
Bacopa may potentiate calcium-channel-blocking effects in vitro. Monitor blood pressure if both taken; clinical relevance unclear.
Both enhance cholinergic activity. No documented serious interactions, but cumulative effect possible.
Protocols featuring Bacopa monnieri
Evidence-backed routines where Bacopa monnieri plays a role.
Memory & Cognitive Aging
longevity
Cognitive function declines gradually starting in the late forties and accelerates around menopause for women and the late sixties for men. The supplement category is over-promoted ("brain pills" are an industry) but a handful of compounds have legitimate trial evidence in age-related cognitive decline. Phosphatidylserine is the most-evidenced compound for memory in older adults. Omega-3 (DHA-dominant) is foundational for brain structure. Citicoline and lion''s mane have emerging evidence. This protocol is distinct from Foundational Longevity (broad aging) and Deep Work Focus (acute cognitive performance) — it specifically targets memory, learning speed, and cognitive resilience as the brain ages. If you have rapid cognitive decline, personality changes, or someone close to you is concerned about your memory in a way you''re not — please see a neurologist. Early dementia is treatable when caught early. Supplements are not a substitute for proper neurological workup.
Pre-Exam / Performance Focus
focus
Short-cycle cognitive enhancement for known demanding cognitive events: exams, important presentations, sales calls, performances, interviews. This is distinct from Deep Work Focus (daily cognitive baseline) and ADHD & Focus for Adults (chronic attention support). The honest framing: most cognitive enhancement on demand comes from the acute L-theanine + caffeine pairing — every other "nootropic" has either smaller effect sizes or longer onset times. Bacopa needs 8-12 weeks to peak (not useful for next-week exams), rhodiola has fast onset but smaller acute effects, and saffron has emerging evidence but needs replication. The structure of this protocol is short-cycle: acute pre-event use (L-theanine + caffeine + L-tyrosine on event day) plus 4-8 weeks of pre-event chronic stack (bacopa) if the exam window is far enough out.
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
How long does bacopa take to work?⌄
8 to 12 weeks of consistent daily use. Bacopa's effects on memory build slowly through structural and neurochemical changes; acute single-dose effects are minimal. If you're looking for next-day cognitive boost, bacopa isn't the right tool.
Why does bacopa upset my stomach?⌄
Bacosides can irritate the GI tract, particularly on an empty stomach. Taking bacopa with meals, especially meals containing fat, substantially reduces nausea and cramping while also improving absorption of the fat-soluble actives.
Is bacopa safe for kids?⌄
Small trials in children with ADHD have used 225 to 300 mg/day for 12 weeks without major safety signals. Long-term safety data in children are limited. Consult a pediatrician before use.
Can I take bacopa with my Alzheimer's medication?⌄
Coordinate with your neurologist. Bacopa modulates acetylcholine availability, which is also the mechanism of cholinesterase inhibitors (donepezil, rivastigmine, galantamine). The combination has not been well characterized and could theoretically cause excessive cholinergic activity.
What's the difference between bacopa and brahmi?⌄
Brahmi is the Sanskrit name for Bacopa monnieri in most modern usage. Confusingly, the same name is sometimes used for Centella asiatica (gotu kola), an unrelated herb with different effects. Look for the scientific name on labels to be sure.
References by claim
Memory in older adults
Cognitive function in healthy adults
Pase et al., 2012 — Journal of Alternative and Complementary Medicine (2012) link
Attention and executive function in children
Track Bacopa monnieri with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.